Skip to main content
. 2022 Nov 27;68(4):283–285. doi: 10.1177/07067437221142283

Figure 1.

Figure 1.

Paired sample t-tests after six brainspotting (BSP) sessions showed a significant [t(8)=3.67, P = .006] drop in posttraumatic stress disorder (PTSD) symptoms as measured by the PTSD checklist for DSM-5 (PCL-5). There were also small improvements in levels of functioning as measured with the Work and Social Functioning (WSAS) scale [t(8)=2.65, P = .03] and the Quick Inventory of Depressive Symptomatology (QIDS; Wilcoxon Signed-Ranks test: Z = −2.13, P = .03).